Method to obtain microparticles containing A H+, K+ -ATP-ASE inhibitor

Details for Australian Patent Application No. 2002235101 (hide)

Owner AstraZeneca AB

Inventors Soderbom, Malin; Glad, Hakan

Agent Freehills

Pub. Number AU-B-2002235101

PCT Pub. Number WO2002/072071

Priority 0100822-6 09.03.01 SE

Filing date 6 March 2002

Wipo publication date 24 September 2002

Acceptance publication date 13 July 2006

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/4439 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-B-2002235101

13 July 2006 Application Accepted

  Published as AU-B-2002235101

31 August 2006 Corrigenda

  Applications Accepted - Name Index Under the name AstraZeneca AB, Application No. 2002235101, under INID (54), amend title to Method to obtain microparticles containing A H+, K+ -ATP-ase inhibitor

9 November 2006 Standard Patent Sealed

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002235102-Method to prepare microparticles that contain metoprolol

2002235100-Method to obtain microparticles containing a H+, K+-ATP-ase inhibitor